Evidence map›Paper›PMID 38262986›Full record

ArticleBMC medical ethics2024

Integrating ethics in AI development: a qualitative study.

Laura Arbelaez Ossa, Giorgia Lorenzini, Stephen R Milford, David Shaw, Bernice S Elger, Michael Rost

Abstract read
In one paragraph

Article in BMC medical ethics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Ethical and Legal Governance of Generative AI in Chinese Healthcare.Journal of multidisciplinary healthcare · 2025
    Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Laura Arbelaez OssaInstitute for Biomedical Ethics, University of Basel, Basel, Switzerland. laura.arbelaezossa@unibas.ch.ORCID 0000-0002-8303-8789
Giorgia LorenziniInstitute for Biomedical Ethics, University of Basel, Basel, Switzerland.ORCID 0000-0002-9155-4724
Stephen R MilfordInstitute for Biomedical Ethics, University of Basel, Basel, Switzerland.ORCID 0000-0002-7325-9940
David ShawInstitute for Biomedical Ethics, University of Basel, Basel, Switzerland.ORCID 0000-0001-8180-6927
Bernice S ElgerInstitute for Biomedical Ethics, University of Basel, Basel, Switzerland.ORCID 0000-0002-4249-7399
Michael RostInstitute for Biomedical Ethics, University of Basel, Basel, Switzerland.ORCID 0000-0001-6537-9793

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung No:407740_187263 /1
6 · The paper itself

Abstract

backgroundWhile the theoretical benefits and harms of Artificial Intelligence (AI) have been widely discussed in academic literature, empirical evidence remains elusive regarding the practical ethical challenges of developing AI for healthcare. Bridging the gap between theory and practice is an essential step in understanding how to ethically align AI for healthcare. Therefore, this research examines the concerns and challenges perceived by experts in developing ethical AI that addresses the healthcare context and needs.

methodsWe conducted semi-structured interviews with 41 AI experts and analyzed the data using reflective thematic analysis.

resultsWe developed three themes that expressed the considerations perceived by experts as essential for ensuring AI aligns with ethical practices within healthcare. The first theme explores the ethical significance of introducing AI with a clear and purposeful objective. The second theme focuses on how experts are concerned about the tension that exists between economic incentives and the importance of prioritizing the interests of doctors and patients. The third theme illustrates the need to develop context-sensitive AI for healthcare that is informed by its underlying theoretical foundations.

conclusionsThe three themes collectively emphasized that beyond being innovative, AI must genuinely benefit healthcare and its stakeholders, meaning AI also aligns with intricate and context-specific healthcare practices. Our findings signal that instead of narrow product-specific AI guidance, ethical AI development may need a systemic, proactive perspective that includes the ethical considerations (objectives, actors, and context) and focuses on healthcare applications. Ethically developing AI involves a complex interplay between AI, ethics, healthcare, and multiple stakeholders.

Indexed as

Artificial IntelligencePhysiciansHumansQualitative ResearchAIAI developmentAI ethicsAI guidanceArtificial intelligenceImplementationQualitative research

Identifiers

PMID38262986
PMCPMC10804710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.